{
  "schema": "pestle.medicine.v1",
  "url": "https://pestle.health/uk/buprenorphine",
  "country": "GB",
  "medicine": "Buprenorphine",
  "activeIngredient": "Buprenorphine (as buprenorphine hydrochloride)",
  "source": {
    "type": "Patient information leaflet approved by the UK medicines regulator (MHRA)",
    "product": "Buprenorphine 0.4mg Sublingual Tablets",
    "licenceNumber": "PL 00142/1109",
    "url": "https://mhraproducts4853.blob.core.windows.net/docs/38eeead921b82f53486a3439461a0a62f14b2e79",
    "leafletDate": "2026-11-13"
  },
  "checkedAgainstSource": "2026-11-19",
  "automatedCheck": {
    "sideEffectsListed": 73,
    "wordingFoundInLeaflet": 73,
    "notFound": 0
  },
  "reviewedBy": null,
  "whatItIsFor": "These are sublingual tablets (placed under the tongue) containing buprenorphine, an opioid. They are used as part of a medical, social and psychological treatment programme for people addicted to opiate (narcotic) drugs, in adults and adolescents over 16 years.",
  "keyFacts": [
    "This medicine is an opioid and can cause addiction. You can get withdrawal symptoms if you stop taking it suddenly, so talk to your doctor before stopping.",
    "Place the tablet under your tongue and let it dissolve. Do not chew, crush or swallow it whole.",
    "It can cause withdrawal symptoms if taken less than six hours after a narcotic such as morphine or heroin, or less than 24 hours after methadone.",
    "Do not drink alcohol while being treated. Alcohol increases the sedative effects and can make driving and operating machinery dangerous.",
    "Keep it in a safe and secure place, as it can be fatal to anyone it has not been prescribed for. Never give it to anyone else."
  ],
  "doNotTake": [
    "Allergic to buprenorphine or any of the other ingredients",
    "Child under 16 years of age",
    "Serious breathing problems",
    "Serious problems with your liver",
    "Intoxicated due to alcohol or have delirium tremens (the shakes and hallucinations)",
    "Breast-feeding",
    "Taking naltrexone or nalmefene for the treatment of alcohol or opioid dependence"
  ],
  "checkWithDoctorFirst": [
    "Asthma or other breathing problems",
    "Liver or kidney problems (you must not take it if you have serious liver insufficiency)",
    "Head injuries or brain disease",
    "Low blood pressure",
    "Enlarged prostate gland, which can make it difficult to pass water",
    "Difficulty passing water because of narrowing of the urethra (urethral stenosis)",
    "Thyroid problems or adrenocortical disorder (e.g. Addison's disease)",
    "Depression or other conditions treated with antidepressants (risk of serotonin syndrome, a potentially life-threatening condition)",
    "Seizures, fits or convulsions",
    "Sleep-related breathing disorders such as sleep apnoea or low blood oxygen during sleep",
    "Higher risk of dependence or addiction if you or your family have abused or been dependent on alcohol, prescription medicines or illegal drugs, if you smoke, or if you have had mood problems or psychiatric treatment",
    "Signs of dependence: taking it for longer or in higher amounts than advised, using it for reasons other than prescribed, repeated failed attempts to quit or control use, or feeling unwell when you stop",
    "Can cause a sudden drop in blood pressure and dizziness if you get up too quickly",
    "May mask pain from some diseases, so tell your doctor you take it",
    "Risk of serious side effects is greater with opioids, alcohol, sedatives and hypnotics, especially benzodiazepines",
    "Misuse, especially by injection and at high dose, is dangerous and could be fatal"
  ],
  "seriousSideEffects": [
    "Allergic reactions including difficulty in breathing, wheezing and swelling of eyes, lips, throat, tongue or hands; skin rash, hives and itching (very rare, may affect up to 1 in 10,000 people)",
    "Severe difficulty in breathing (respiratory depression) (common, may affect up to 1 in 100 people)",
    "Bronchitis (infection of the airways) (common, may affect up to 1 in 10 people)",
    "Arrhythmias (common, may affect up to 1 in 10 people)",
    "Severe fatigue, loss of appetite or yellowing of skin and eyes, which may be symptoms of liver damage such as hepatitis or death of liver cells (not known)",
    "Seizures (not known)"
  ],
  "sideEffectsByFrequency": [
    {
      "frequency": "Very common",
      "meaning": "More than 1 in 10 people",
      "effects": [
        "Not being able to sleep",
        "Headache",
        "Nausea",
        "Excessive sweating",
        "Pain"
      ]
    },
    {
      "frequency": "Common",
      "meaning": "Up to 1 in 10 people",
      "effects": [
        "Severe difficulty in breathing (respiratory depression)",
        "Bronchitis (infection of the airways)",
        "Arrhythmias",
        "Infections",
        "The flu",
        "Sore throat",
        "Runny nose",
        "Swollen or enlarged glands (lymph nodes)",
        "Decreased appetite",
        "Agitation",
        "Anxiety",
        "Depression",
        "Hostility",
        "Nervousness",
        "Paranoia",
        "Abnormal thoughts",
        "Hallucination",
        "Dizziness",
        "Increased muscle tone",
        "Migraine",
        "Pins and needles",
        "Drowsiness",
        "Fainting",
        "Tremor",
        "Disorders of the tear ducts",
        "Vision impairment (dilated or constricted pupils)",
        "Feeling of dizziness or spinning",
        "Faster or irregular heartbeat (palpitations)",
        "Widening of blood vessels",
        "Drop in blood pressure on changing position from sitting or lying down to standing",
        "Cough",
        "Shortness of breath",
        "Yawning",
        "Abdominal pain",
        "Constipation",
        "Diarrhoea",
        "Dry mouth",
        "Indigestion",
        "Stomach complaints",
        "Passing wind",
        "Tooth disorder",
        "Vomiting",
        "Rash",
        "Joint pain",
        "Back pain",
        "Bone pain",
        "Muscle spasms",
        "Muscle pain",
        "Neck pain",
        "Painful periods in women",
        "Physical weakness/fatigue",
        "Chest pain",
        "Chills",
        "A general feeling of discomfort, illness or unease",
        "Swelling in the lower legs or hands",
        "Fever"
      ]
    },
    {
      "frequency": "Uncommon",
      "meaning": "Up to 1 in 100 people",
      "effects": [
        "Double vision",
        "Pink eye (conjunctivitis)",
        "Difficulty passing urine",
        "Pain or cramps in the lower abdomen (urinary disorders)"
      ]
    },
    {
      "frequency": "Very rare",
      "meaning": "Up to 1 in 10,000 people",
      "effects": [
        "Allergic reactions including difficulty in breathing, wheezing and swelling of eyes, lips, throat, tongue or hands; skin rash, hives and itching"
      ]
    },
    {
      "frequency": "Not known",
      "meaning": "The leaflet says how often is not known",
      "effects": [
        "Severe fatigue",
        "Loss of appetite",
        "Yellowing of skin and eyes",
        "Liver damage such as hepatitis or death of the cells of the liver (necrosis of the liver)",
        "Seizures",
        "Dependence and addiction",
        "Dental caries"
      ]
    }
  ],
  "otherMedicinesTheLeafletMentions": [
    "Naltrexone and nalmefene (must not be used with buprenorphine)",
    "Other medicines with sedative properties, including sedating antihistamines, certain antidepressants and clonidine",
    "Strong painkillers (opioid analgesics) and cough medicines containing opioid-related substances such as methadone and codeine",
    "Barbiturates and other medicines for sleep disorders, anxiety or convulsions",
    "Monoamine oxidase inhibitors (a type of antidepressant)",
    "Antidepressants such as moclobemide, tranylcypromine, citalopram, escitalopram, fluoxetine, fluvoxamine, paroxetine, sertraline, duloxetine, venlafaxine, amitriptyline, doxepin or trimipramine",
    "Medicines to treat psychiatric disorders (antipsychotics or neuroleptics)",
    "HIV/AIDS medicines (protease inhibitors) including indinavir, ritonavir, nelfinavir and saquinavir",
    "Anti-epileptic medicines including phenobarbital, carbamazepine and phenytoin",
    "Antibiotics including rifampicin and erythromycin",
    "Antifungal medicines including ketoconazole and itraconazole",
    "Gabapentin or pregabalin",
    "Medicines for allergies, travel sickness or nausea (antihistamines or antiemetics)",
    "Muscle relaxants",
    "Medicines to treat Parkinson's disease",
    "Benzodiazepines or related sedative medicines (can cause drowsiness, breathing difficulty, coma and may be life-threatening)",
    "Alcohol and medicines containing alcohol",
    "Street drugs and any prescription medicines not prescribed to you"
  ],
  "pregnancyAndBreastfeeding": "Do not take these tablets if you are pregnant or think you might be pregnant unless you have discussed it with your doctor and the benefits are considered to outweigh the potential harm to the baby. Do not take them while breast-feeding, as buprenorphine passes into breast milk and will affect your baby.",
  "howToTake": [
    "Always take exactly as your doctor has told you, and check with your doctor or pharmacist if you are not sure.",
    "Place the tablet under your tongue and allow it to dissolve. This is the only way to take it. Do not chew, crush or swallow whole.",
    "Take the dose once a day, unless your doctor prescribes otherwise. Your doctor will decide the dose and may adjust it depending on your response.",
    "Do not stop suddenly or change your treatment without your doctor's agreement. Your doctor will usually reduce the dose gradually.",
    "If you forget a dose, contact your doctor. Do not take a double dose unless your doctor tells you to."
  ],
  "notice": "Reference information taken from the official leaflet. Not medical advice. Other makers of the same medicine may publish slightly different leaflets."
}